Company intelligence / Profile preview

Guangzhou Kuentai Biotechnology

Guangzhou, Guangdong, China

Ownership: Private
Development stage: Other

Overview

Guangzhou Kuntai Biotechnology is a Chinese biotechnology company based in Guangzhou that focuses on medical research and the development of advanced therapeutic technologies. Established in 2023, the company's business scope includes the research and development of human stem cell technology, gene diagnosis, and therapeutic applications. While currently in the early stages of development, the company aims to leverage biotechnology innovations to address complex medical needs. It operates within the broader life sciences ecosystem of the Guangdong province, specializing in technology promotion and application services.

Modalities: Cell therapyBiologic
Industry: Biotech

Beyond the preview

Go deeper on Guangzhou Kuentai Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guangzhou Kuentai Biotechnology.

Explore the full profile